X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-04-30 | HNVR | Wilcox McClelland W | Pres | P - Purchase | $16.60 | +250 | 81,537 | 0% | +$4,150 | ||||||
2024-04-30 | HNVR | Puorro Michael P | COB, CEO | P - Purchase | $16.60 | +500 | 278,388 | 0% | +$8,300 | ||||||
2024-04-30 | HNVR | Burke Lance P | EVP, CFO | P - Purchase | $16.60 | +200 | 21,371 | +1% | +$3,320 | ||||||
2024-04-24 | HNVR | Burke Lance P | EVP, CFO | P - Purchase | $16.78 | +200 | 21,171 | +1% | +$3,356 | ||||||
2024-04-24 | HNVR | Vivona John P | FSVP, Chief Risk Officer | P - Purchase | $16.79 | +200 | 3,200 | +7% | +$3,357 | ||||||
| M | 2024-04-23 | HNVR | Puorro Michael P | COB, CEO | P - Purchase | $16.84 | +400 | 277,888 | 0% | +$6,736 | |||||
2024-04-22 | HNVR | Sisti Elena | Dir | P - Purchase | $16.95 | +2,000 | 152,896 | +1% | +$33,900 | ||||||
2024-04-22 | HNVR | Wilcox McClelland W | Pres | P - Purchase | $16.91 | +200 | 81,287 | 0% | +$3,382 | ||||||
2024-04-22 | HNVR | Puorro Michael P | COB, CEO | P - Purchase | $16.58 | +200 | 277,488 | 0% | +$3,316 | ||||||
2024-01-31 | HNVR | Golden Robert | Dir | P - Purchase | $18.00 | +500 | 454,421 | 0% | +$9,000 | ||||||
2024-01-29 | HNVR | Sisti Elena | Dir | P - Purchase | $18.01 | +2,750 | 148,779 | +2% | +$49,528 | ||||||
2024-01-29 | HNVR | Katz Michael David M.D. | Dir | P - Purchase | $18.02 | +700 | 241,930 | 0% | +$12,614 | ||||||
2023-12-08 | HNVR | Okun Philip A | Dir | S - Sale | $17.75 | -1,124 | 32,328 | -3% | -$19,954 | ||||||
2023-11-08 | HNVR | Sisti Elena | Dir | P - Purchase | $18.00 | +265 | 146,029 | 0% | +$4,770 | ||||||
| A | 2022-05-11 | HNVR | Puorro Michael P | COB, CEO | P - Purchase | $21.00 | +4,820 | 256,543 | +2% | +$101,220 | |||||
| M | 2022-08-11 | HNVR | Katz Michael David M.D. | Dir | P - Purchase | $20.06 | +65 | 239,618 | 0% | +$1,304 | |||||
2022-05-11 | HNVR | Wilcox McClelland W | SEVP, C.Lending, Revenue Offic | P - Purchase | $21.00 | +5,000 | 59,429 | +9% | +$105,000 | ||||||
2022-05-11 | HNVR | Rouse Alice T | EVP, Chief Risk Officer | P - Purchase | $21.00 | +2,000 | 24,487 | +9% | +$42,000 | ||||||
2022-05-11 | HNVR | Finneran Brian K | Pres | P - Purchase | $21.00 | +2,500 | 87,029 | +3% | +$52,500 | ||||||
2022-05-11 | HNVR | Diiorio Lisa A | FSVP, Chief Accounting Officer | P - Purchase | $21.00 | +1,000 | 14,747 | +7% | +$21,000 | ||||||
2022-05-11 | HNVR | Corbett Kevin | EVP, Chief Credit Officer | P - Purchase | $21.00 | +5,000 | 18,438 | +37% | +$105,000 | ||||||
2022-05-11 | HNVR | Burke Lance P | EVP, CFO | P - Purchase | $21.00 | +2,000 | 16,934 | +13% | +$42,000 | ||||||
2022-05-11 | HNVR | Sorrenti John R | Dir | P - Purchase | $21.00 | +2,500 | 33,500 | +8% | +$52,500 | ||||||
2022-05-11 | HNVR | Sisti Elena | Dir | P - Purchase | $21.00 | +8,000 | 140,768 | +6% | +$168,000 | ||||||
2022-05-11 | HNVR | Okun Philip A | Dir | P - Purchase | $21.00 | +3,000 | 31,840 | +10% | +$63,000 | ||||||
2022-05-11 | HNVR | Negrin Metin | Dir | P - Purchase | $21.00 | +8,000 | 231,995 | +4% | +$168,000 | ||||||
2022-05-11 | HNVR | Katz Michael David M.D. | Dir | P - Purchase | $21.00 | +5,000 | 239,553 | +2% | +$105,000 | ||||||
2022-05-11 | HNVR | Haspel Ahron H | Dir | P - Purchase | $21.00 | +5,000 | 58,567 | +9% | +$105,000 | ||||||
2022-05-11 | HNVR | Golden Robert | Dir | P - Purchase | $21.00 | +5,000 | 366,540 | +1% | +$105,000 | ||||||
2022-05-11 | HNVR | Abraham Varkey | Dir | P - Purchase | $21.00 | +2,500 | 49,134 | +5% | +$52,500 | ||||||
2022-05-11 | HNVR | Puorro Michael P | COB, CEO | P - Purchase | $21.00 | +5,000 | 256,723 | +2% | +$105,000 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |